| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55533 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-117
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2004-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2012-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101126030-B1 |
| titleOfInvention |
Method of co-stimulating the immune system using immunostimulatory oligonucleotides and / or immunomer compounds in conjunction with cytokines and / or chemotherapeutic agents or radiation therapy |
| abstract |
The present invention is directed to enhancing an immune response induced by an immunostimulatory compound used for the treatment of a patient's cancer, including autoimmune disorders, asthma, respiratory allergies, food allergies, and infectious diseases. Optimized methods and compositions are provided. The optimized method according to the present invention provides a synergistic action between the therapeutic effect of immunostimulatory oligonucleotides and immunomeric compounds according to the invention and the therapeutic effect of cytokine immunotherapy and / or chemotherapeutic agents and / or radiation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102357566-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200114767-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200114769-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102289054-B1 |
| priorityDate |
2003-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |